Search Results 901-910 of 18372 for Immunode

1. A Study to Evaluate MEDI2228 in Subjects with Relapsed/ Refractory Multiple Myeloma - Mayo Clinic

   Known history of human immunodeficiency virus (HIV) or active hepatitis B virus (HBV) or hepatitis C virus (HCV) infections at the time of screening which are ...

2. A Study to Evaluate the Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer - Mayo Clinic

   Has a known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies). Has known active Hepatitis B (e.g., HBsAg reactive) or Hepatitis C (e.g. ...

3. A Phase 2 Study Of PRM-151 In Subjects With Myelofibrosis - Mayo Clinic

   Known history of human immunodeficiency virus (HIV), or known active hepatitis A, B, or C infection;; Organ transplant recipients other than bone marrow ...

4. Publications - Amir A. Sadighi Akha, M.D., Ph.D. - Mayo Clinic

   A Toolkit and Framework for Optimal Laboratory Evaluation of Individuals with Suspected Primary Immunodeficiency. J Allergy Clin Immunol Pract. 2021 Sep; 9 ...

5. A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM) (KarMMa-4) - Mayo Clinic

   Subject is seropositive for human immunodeficiency virus, chronic or active hepatitis B or active hepatitis A or C. Participating Mayo Clinic locations.

6. A Study to Evaluate the Safety and Tolerability of DCC-2618 in Patients with Advanced Malignancies - Mayo Clinic

   Known human immunodeficiency virus or hepatitis C infection only if the patient is taking medications that are described in Section 5.8.2.2, active ...

7. Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors - Mayo Clinic

   ... immunodeficiency virus (HIV) infection, or active Hepatitis B or Hepatitis C]. Use of other investigational agents within 30 days or 5 half-lives prior to ...

8. A Study of ASTX660 Alone or Combined with ASTX727 in Subjects with Relapsed/Refractory Acute Myeloid Leukemia (AML) - Mayo Clinic

   Known human immunodeficiency virus (HIV), active hepatitis B virus (HBV), or active hepatitis C virus (HCV) infection (participants with laboratory evidence ...

9. Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy - Mayo Clinic

   ... immunodeficiency. Unwillingness to avoid household contacts ≤ 15 months old or household contact with known immunodeficiency 1 week after treatment.

10. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

    History of primary immunodeficiency, allogeneic bone marrow transplantation, solid organ transplantation, or previous clinical diagnosis of tuberculosis.